Page 41 - medicina-integrativa_compress

30 PARTE I MEDICINA INTEGRATIVA

23. Luscombe CJ, Fryer AA, French ME, et al: Exposure to ultraviolet 47. Neel JV: Diabetes mellitus: A “thrifty” genotype rendered
radiation: Association with susceptibility and age at presentation detrimental by “progress”? Am J Hum Genet 14:353-362, 1962.
with prostate cancer. Lancet 358:641-642, 2001. 48. Manson JE, Rimm EB, Stampfer MJ, et al: Physical activity and
24. John EM, Schwartz GG, Koo J, et al: Sun exposure, vitamin D incidence of non-insulin-dependent diabetes mellitus in women.
receptor gene polymorphisms, and risk of advanced prostate cancer. Lancet 338:774-778, 1991.
Cancer Res 65:5470-5479, 2005. 49. Hamman RF: Genetic and environmental determinants of non-
25. Miller AL: Epidemiology, etiology, and natural treatment of seasonal insulin-dependent diabetes mellitus (NIDDM). Diabetes Metab Rev
affective disorder. Altern Med Rev 10:5-13, 2005. 8:287-338, 1992.
26. Roseman C, Booker JM: Workload and environmental factors in 50. Hu FB, Manson JE, Stampfer MJ, et al: Diet, lifestyle, and the risk of
hospital medication errors. Nurs Res 44:226-230, 1995. type 2 diabetes mellitus in women. N Engl J Med 345:790-797, 2001.
27. Willeit M, Praschak-Rieder N, Neumeister A, et al: A polymorphism 51. Tuomilehto J, Lindstrom J, Eriksson JG, et al: Prevention of type 2
(5-HTTLPR) in the serotonin transporter promoter gene is diabetes mellitus by changes in lifestyle among subjects with
associated with DSM-IV depression subtypes in seasonal affective impaired glucose tolerance. N Engl J Med 344:1343-1350, 2001.
disorder. Mol Psychiatry 8:942-946, 2003. 52. Knowler WC, Barrett-Connor E, Fowler SE, et al: Reduction in the
28. Willeit M, Praschak-Rieder N, Zill P, et al: C825T polymorphism in incidence of type 2 diabetes with lifestyle intervention or metformin.
the G protein beta-3 subunit gene is associated with seasonal N Engl J Med 346:393-403, 2002.
affective disorder. Biol Psychiatry 54:682-686, 2003. 53. Neel JV: Diabetes mellitus: A “thrifty” genotype rendered
29. Jones PA: Epigenetics in carcinogenesis and cancer prevention. Ann detrimental by “progress”? 1962. Bull World Health Organ 77:
N Y Acad Sci 983:213-219, 2003. 694-703; discussion 692-693, 1999.
30. Toyota M, Issa JP: CpG island methylator phenotypes in aging and 54. Hales CN, Barker DJ: The thrifty phenotype hypothesis. Br Med Bull
cancer. Semin Cancer Biol 9:349-357, 1999. 60:5-20, 2001.
31. Baylin SB, Belinsky SA, Herman JG: Aberrant methylation of gene 55. Trevisan R, Vedovato M, Tiengo A: The epidemiology of diabetes
promoters in cancer: Concepts, misconcepts, and promise. J Natl mellitus. Nephrol Dial Transplant 13(Suppl 8):2-5, 1998.
Cancer Inst 92:1460-1461, 2000. 56. Ravussin E, Valencia ME, Esparza J, et al: Effects of a traditional
32. Di Croce L, Raker VA, Corsaro M, et al: Methyltransferase lifestyle on obesity in Pima Indians. Diabetes Care 17:1067-1074,
recruitment and DNA hypermethylation of target promoters by an 1994.
oncogenic transcription factor. Science 295:1079-1082, 2002. 57. Knowler WC, Bennett PH, Hamman RF, Miller M: Diabetes
33. Hemminki K, Vaittinen P: Familial cancers in a nationwide family incidence and prevalence in Pima Indians: A 19-fold greater
cancer database: Age distribution and prevalence. Eur J Cancer incidence than in Rochester, Minnesota. Am J Epidemiol
35:1109-1117, 1999. 108:497-505, 1978.
34. Lichtenstein P, Holm NV, Verkasalo PK, et al: Environmental and 58. Swinburn BA, Boyce VL, Bergman RN, et al: Deterioration in
heritable factors in the causation of cancer: Analyses of cohorts carbohydrate metabolism and lipoprotein changes induced by
of twins from Sweden, Denmark, and Finland. N Engl J Med modern, high-fat diet in Pima Indians and Caucasians. J Clin
343:78-85, 2000. Endocrinol Metab 73:156-165, 1991.
35. Palmisano WA, Divine KK, Saccomanno G, et al: Predicting lung 59. Levy E, Menard D, Delvin E, et al: The polymorphism at codon 54
cancer by detecting aberrant promoter methylation in sputum. of the FABP2 gene increases fat absorption in human intestinal
Cancer Res 60:5954-5958, 2000. explants. J Biol Chem 276:39679-39684, 2001.
36. Issa JP, Baylin SB, Belinsky SA: Methylation of the estrogen receptor 60. Pratley RE, Baier L, Pan DA, et al: Effects of an Ala54Thr
CpG island in lung tumors is related to the specific type of polymorphism in the intestinal fatty acid-binding protein on
carcinogen exposure. Cancer Res 56:3655-3658, 1996. responses to dietary fat in humans. J Lipid Res 41:2002-2008,
37. Kastan MB, Lim DS, Kim ST, Yang D: ATM—a key determinant of 2000.
multiple cellular responses to irradiation. Acta Oncol 40:686-688, 61. Baier LJ, Sacchettini JC, Knowler WC, et al: An amino acid
2001. substitution in the human intestinal fatty acid binding protein is
38. King MC, Marks JH, Mandell JB: Breast and ovarian cancer associated with increased fatty acid binding, increased fat oxidation,
risks due to inherited mutations in BRCA1 and BRCA2. Science and insulin resistance. J Clin Invest 95:1281-1287, 1995.
302:643-646, 2003. 62. Salguero ML, Leon RE, Santos A, et al: The role of FABP2 gene
39. Ziegler RG, Hoover RN, Pike MC, et al: Migration patterns and polymorphism in alcoholic cirrhosis. Hepatol Res 33:306-312,
breast cancer risk in Asian American women. J Natl Cancer Inst 2005.
85:1819-1827, 1993. 63. Eaker ED, Sullivan LM, Kelly-Hayes M, et al: Anger and hostility
40. Ross R, Schottenfeld D: Prostate cancer. In Schottenfeld D, predict the development of atrial fibrillation in men in the
Fraumeni JF Jr (eds): Cancer Epidemiology and Prevention, 2nd ed. Framingham Offspring Study. Circulation 109:1267-1271, 2004.
New York, Oxford University Press, 1996, pp 1180-1206. 64. Clark A, Seidler A, Miller M: Inverse association between sense
41. Merritt AJ, Gould KA, Dove WF: Polyclonal structure of intestinal of humor and coronary heart disease. Int J Cardiol 80:87-88,
adenomas in ApcMin/+ mice with concomitant loss of Apc+ from 2001.
all tumor lineages. Proc Natl Acad Sci U S A 94:13927-13931, 1997. 65. Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES: The sympathetic
42. Pitot HC, Jost JP: Control of biochemical expression in nerve: An integrative interface between two supersystems—the brain
morphologically related cells in vivo and in vitro. Natl Cancer Inst and the immune system. Pharmacol Rev 52:595-638, 2000.
Monogr 26:145-166, 1967. 66. Eskandari F, Sternberg EM: Neural-immune interactions in health
43. Merlo A, Herman JG, Mao L, et al: 5 CpG island methylation is and disease. Ann N Y Acad Sci 966:20-27, 2002.
associated with transcriptional silencing of the tumour suppressor 67. Saint-Mezard P, Chavagnac C, Bosset S, et al: Psychological stress
p16/CDKN2/MTS1 in human cancers. Nat Med 1:686-692, 1995. exerts an adjuvant effect on skin dendritic cell functions in vivo.
44. Ottaviano YL, Issa JP, Parl FF, et al: Methylation of the estrogen J Immunol 171:4073-4080, 2003.
receptor gene CpG island marks loss of estrogen receptor expression 68. Li QZ, Li P, Garcia GE, et al: Genomic profiling of neutrophil
in human breast cancer cells. Cancer Res 54:2552-2555, 1994. transcripts in Asian Qigong practitioners: A pilot study in gene
45. Toyota M, Ho C, Ahuja N, et al: Identification of differentially regulation by mind-body interaction. J Altern Complement Med
methylated sequences in colorectal cancer by methylated CpG island 11:29-39, 2005.
amplification. Cancer Res 59:2307-2312, 1999. 69. Roth GS, Ingram DK, Lane MA: Caloric restriction in primates and
46. Ebert MN, Klinder A, Peters WH, et al: Expression of glutathione relevance to humans. Ann N Y Acad Sci 928:305-315, 2001.
S-transferases (GSTs) in human colon cells and inducibility of 70. Smith JA: Neutrophils, host defense, and inflammation: A double-
GSTM2 by butyrate. Carcinogenesis 24:1637-1644, 2003. edged sword. J Leukoc Biol 56:672-686, 1994.